SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-034263
Filing Date
2020-02-13
Accepted
2020-02-13 07:40:13
Documents
14
Period of Report
2020-02-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d893281d8k.htm   iXBRL 8-K 28270
2 EX-99.1 d893281dex991.htm EX-99.1 58821
6 GRAPHIC g893281dsp04a.jpg GRAPHIC 2956
  Complete submission text file 0001193125-20-034263.txt   220936

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agio-20200213.xsd EX-101.SCH 3049
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20200213_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20200213_pre.xml EX-101.PRE 10939
15 EXTRACTED XBRL INSTANCE DOCUMENT d893281d8k_htm.xml XML 3236
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 20606957
SIC: 2834 Pharmaceutical Preparations